Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esther F Vicente-Rabaneda

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Pharmaceuticals (Basel, Switzerland)|August 28, 2021
Pharmacological Interactions of Nintedanib and Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis in Times of COVID-19 PandemicJosé M Serra López-Matencio, Manuel Gómez, Esther F Vicente-Rabaneda, et al.
Expert Review of Clinical Immunology|March 10, 2023
Challenges in the diagnosis of polymyalgia rheumatica and related giant cell arteritisMiguel A González-Gay, Esther F Vicente-Rabaneda, Juan A Martínez-López, et al.
Journal of Clinical Medicine|February 24, 2024
Application of Nuclear Medicine Techniques in Musculoskeletal Infection: Current Trends and Future ProspectsCristina Valero-Martínez, Valentina Castillo-Morales, Nieves Gómez-León, et al.
Journal of Clinical Medicine|November 9, 2024
IgA Vasculitis (Henoch-Schönlein Purpura): An Update on TreatmentSantos Castañeda, Patricia Quiroga-Colina, Paz Floranes, et al.
Expert Opinion on Pharmacotherapy|April 30, 2026
Targeted small molecules in Polymyalgia Rheumatica: the emerging role of jak inhibitors beyond glucocorticoids and DMARDsMiguel Ángel Gonzalez-Gay, Miguel Álvarez-Rubio, Ana de Benito-Vernière, et al.
Journal of Clinical Medicine|March 25, 2022
Advances in the Treatment of Giant Cell ArteritisSantos Castañeda, Diana Prieto-Peña, Esther F Vicente-Rabaneda, et al.
Expert Opinion on Pharmacotherapy|June 15, 2026
Emerging pharmacotherapies for large-vessel vasculitisEsther F Vicente-Rabaneda, Marina Dueñas-Ochoa, Patricia Muñoz Hernández, et al.
Clinical and Experimental Rheumatology|May 15, 2025
Association of serum myeloperoxidase with metabolic syndrome and adverse lipid profiles in scleroderma patientsIván Ferraz-Amaro, Zena Ibrahim-Achi, Antonia de Vera-González, et al.
Clinical and Experimental Rheumatology|May 15, 2025
ADAMTS13 and insulin resistance in systemic sclerosis patientsIván Ferraz-Amaro, Zena Ibrahim-Achi, Antonia de Vera-González, et al.
Clinical and Experimental Rheumatology|March 17, 2025
Neutrophil gelatinase-associated lipocalin levels are associated with skin thickness and metabolic syndrome features in patients with systemic sclerosisIván Ferraz-Amaro, Santos Castañeda, Zena Ibrahim-Achi, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Pharmaceuticals (Basel, Switzerland)|August 28, 2021
Pharmacological Interactions of Nintedanib and Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis in Times of COVID-19 PandemicJosé M Serra López-Matencio, Manuel Gómez, Esther F Vicente-Rabaneda, et al.
Expert Review of Clinical Immunology|March 10, 2023
Challenges in the diagnosis of polymyalgia rheumatica and related giant cell arteritisMiguel A González-Gay, Esther F Vicente-Rabaneda, Juan A Martínez-López, et al.
Journal of Clinical Medicine|February 24, 2024
Application of Nuclear Medicine Techniques in Musculoskeletal Infection: Current Trends and Future ProspectsCristina Valero-Martínez, Valentina Castillo-Morales, Nieves Gómez-León, et al.
Journal of Clinical Medicine|November 9, 2024
IgA Vasculitis (Henoch-Schönlein Purpura): An Update on TreatmentSantos Castañeda, Patricia Quiroga-Colina, Paz Floranes, et al.
Expert Opinion on Pharmacotherapy|April 30, 2026
Targeted small molecules in Polymyalgia Rheumatica: the emerging role of jak inhibitors beyond glucocorticoids and DMARDsMiguel Ángel Gonzalez-Gay, Miguel Álvarez-Rubio, Ana de Benito-Vernière, et al.
Journal of Clinical Medicine|March 25, 2022
Advances in the Treatment of Giant Cell ArteritisSantos Castañeda, Diana Prieto-Peña, Esther F Vicente-Rabaneda, et al.
Expert Opinion on Pharmacotherapy|June 15, 2026
Emerging pharmacotherapies for large-vessel vasculitisEsther F Vicente-Rabaneda, Marina Dueñas-Ochoa, Patricia Muñoz Hernández, et al.
Clinical and Experimental Rheumatology|May 15, 2025
Association of serum myeloperoxidase with metabolic syndrome and adverse lipid profiles in scleroderma patientsIván Ferraz-Amaro, Zena Ibrahim-Achi, Antonia de Vera-González, et al.
Clinical and Experimental Rheumatology|May 15, 2025
ADAMTS13 and insulin resistance in systemic sclerosis patientsIván Ferraz-Amaro, Zena Ibrahim-Achi, Antonia de Vera-González, et al.
Clinical and Experimental Rheumatology|March 17, 2025
Neutrophil gelatinase-associated lipocalin levels are associated with skin thickness and metabolic syndrome features in patients with systemic sclerosisIván Ferraz-Amaro, Santos Castañeda, Zena Ibrahim-Achi, et al.
Pageof 5